Biotech entity
Barclays is most often covered alongside Bank of America, which appears in 2 of these 2 stories. Across a 31-day span, the pace is roughly 0.5 stories per week. Source depth averages 2.5 original sources per story, versus 4.4 across the same-window beat baseline.
Last mentioned: Sep 4, 2026
Entity pulse
Figures are computed live from our source-verified story record — see our methodology for how impact and sentiment are derived.
Barclays is most often covered alongside Bank of America, which appears in 2 of these 2 stories. Across a 31-day span, the pace is roughly 0.5 stories per week. Source depth averages 2.5 original sources per story, versus 4.4 across the same-window beat baseline. The 5 average consequence score is below the beat benchmark of 6.3 in the same window. Coverage clusters in gene-therapy, which accounts for 1 of those 2, with the remainder spread across 1 other category. We currently track 2 Biotech stories that mention Barclays, published between July 6, 2026 and August 5, 2026.
Computed from the 2 stories linked to this entity, with beat comparisons drawn from all 168 Biotech stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.
Coverage cohort
Other entities that clear the same relevance threshold in stories also covering Barclays. Shared-story counts are live from our verified record — not editorial picks.
Teva's fiscal 2026 EPS guidance, well below the Street's $2.17, raises red flags for biotech and pharma investors. However, a $42 average price target and stable revenue suggest a value play if the biosimilar pipeline delivers.
Source: tickerreport.com · themarketsdaily.com
REGENXBIO Chief Medical Officer Steve Pakola offloaded 56,333 shares for $688,756 following a disastrous Q1 miss, but analysts maintain price targets implying up to 99% upside. The insider sales add tension to a gene therapy story already defined by high risk and potential reward.
Source: Zolmax · Markets Daily
Barclays is linked from 2 stories on this site, each scored at or above our 35% relevance threshold — see how these pages are built.
See something wrong on this page — a misattributed entity, a wrong stat, a broken source link? Report a data issue.
